{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T04:17:44Z","timestamp":1790741864691,"version":"4.1.0"},"reference-count":29,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"crossref","award":["APP1027624"],"award-info":[{"award-number":["APP1027624"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"crossref","award":["GNT1194667"],"award-info":[{"award-number":["GNT1194667"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"crossref","award":["#2008382"],"award-info":[{"award-number":["#2008382"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100009399","name":"Macular Disease Foundation Australia","doi-asserted-by":"crossref","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}],"id":[{"id":"10.13039\/100009399","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,7]]},"abstract":"<jats:sec>\n            <jats:title>Purpose:<\/jats:title>\n            <jats:p>There is a need for robust earlier biomarkers of atrophic age-related macular degeneration that could act as surrogate endpoints for geographic atrophy (GA) in early interventional trials. This study sought to examine the risk of progression of complete retinal pigment epithelium and outer retinal atrophy (cRORA) to the traditional atrophic endpoint of GA on color fundus photography. This study also compared the risk of progression for cRORA to that associated with the specific optical coherence tomography features that define nascent GA (nGA), a strong predictor of GA development.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>One hundred forty participants with bilateral large drusen at baseline underwent optical coherence tomography imaging and color fundus photography at 6-month intervals for up to 36 months. Optical coherence tomography volume scans were graded for the presence of cRORA and nGA, and color fundus photographs were graded for the presence of GA. The association and rate of progression to GA for cRORA and nGA were examined.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Both cRORA and nGA were significantly associated with GA development (adjusted hazard ratio, 65.7 and 76.8 respectively; both <jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.001). The probability of progression of cRORA to GA over 24 months (26%) was significantly lower than the probability of progression of nGA (38%; <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.039).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>This study confirmed that cRORA was a significant risk factor for developing GA, although its rate of progression was slightly lower compared with nGA. While requiring replication in future studies, these findings suggest that the specific features of photoreceptor degeneration used to define nGA appear important when assessing the risk of progression.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/iae.0000000000004080","type":"journal-article","created":{"date-parts":[[2024,3,7]],"date-time":"2024-03-07T22:00:10Z","timestamp":1709848810000},"page":"1224-1231","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":12,"title":["COMPLETE RETINAL PIGMENT EPITHELIAL AND OUTER RETINAL ATROPHY IN AGE-RELATED MACULAR DEGENERATION"],"prefix":"10.1097","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8623-6684","authenticated-orcid":false,"given":"Zhichao","family":"Wu","sequence":"first","affiliation":[{"name":"Centre for Eye Research Australia, Royal Victorian Eye and Ear Hospital, East Melbourne, Australia; and"},{"name":"Ophthalmology, Department of Surgery, The University of Melbourne, Melbourne, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren A.B.","family":"Hodgson","sequence":"additional","affiliation":[{"name":"Centre for Eye Research Australia, Royal Victorian Eye and Ear Hospital, East Melbourne, Australia; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai Lyn","family":"Goh","sequence":"additional","affiliation":[{"name":"Centre for Eye Research Australia, Royal Victorian Eye and Ear Hospital, East Melbourne, Australia; and"},{"name":"Ophthalmology, Department of Surgery, The University of Melbourne, Melbourne, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robyn H.","family":"Guymer","sequence":"additional","affiliation":[{"name":"Centre for Eye Research Australia, Royal Victorian Eye and Ear Hospital, East Melbourne, Australia; and"},{"name":"Ophthalmology, Department of Surgery, The University of Melbourne, Melbourne, Australia."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250605","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1001\/archopht.119.10.1417","article-title":"A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS Report No. 8","volume":"119","year":"2001","journal-title":"Arch Ophthalmol"},{"key":"R2-20250605","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1001\/jama.2013.4997","article-title":"Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration: the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial","volume":"309","year":"2013","journal-title":"JAMA"},{"key":"R3-20250605","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.oret.2017.08.018","article-title":"Design characteristics of geographic atrophy treatment trials: systematic review of registered trials in ClinicalTrials.gov","volume":"2","author":"Cheng","year":"2018","journal-title":"Ophthalmol Retina"},{"key":"R4-20250605","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1001\/jamaophthalmol.2018.1544","article-title":"Efficacy and safety of lampalizumab for geographic atrophy due to age-related macular degeneration: chroma and spectri phase 3 randomized clinical trials","volume":"136","author":"Holz","year":"2018","journal-title":"JAMA Ophthalmol"},{"key":"R5-20250605","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.ophtha.2019.07.011","article-title":"Complement C3 inhibitor pegcetacoplan for geographic atrophy secondary to age-related macular degeneration: a randomized phase 2 trial","volume":"127","author":"Liao","year":"2020","journal-title":"Ophthalmology"},{"key":"R6-20250605","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.ophtha.2020.08.027","article-title":"C5 inhibitor avacincaptad pegol for geographic atrophy due to age-related macular degeneration: a randomized pivotal phase 2\/3 trial","volume":"128","author":"Jaffe","year":"2021","journal-title":"Ophthalmology"},{"key":"R7-20250605","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.1016\/j.ophtha.2014.06.034","article-title":"Optical coherence tomography defined changes preceding the development of drusen-associated atrophy in age-related macular degeneration","volume":"121","author":"Wu","year":"2014","journal-title":"Ophthalmology"},{"key":"R8-20250605","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1167\/iovs.14-16211","article-title":"Fundus autofluorescence characteristics of nascent geographic atrophy in age-related macular degeneration","volume":"56","author":"Wu","year":"2015","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R9-20250605","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.oret.2019.12.011","article-title":"Prospective longitudinal evaluation of nascent geographic atrophy in age-related macular degeneration","volume":"4","author":"Wu","year":"2020","journal-title":"Ophthalmol Retina"},{"key":"R10-20250605","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.ophtha.2017.09.028","article-title":"Consensus definition for atrophy associated with age-related macular degeneration on OCT: classification of atrophy report 3","volume":"125","author":"Sadda","year":"2018","journal-title":"Ophthalmology"},{"key":"R11-20250605","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.ophtha.2019.09.035","article-title":"Incomplete retinal pigment epithelial and outer retinal atrophy in age-related macular degeneration: classification of atrophy meeting report 4","volume":"127","author":"Guymer","year":"2020","journal-title":"Ophthalmology"},{"key":"R12-20250605","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.ophtha.2022.09.004","article-title":"Incomplete retinal pigment epithelial and outer retinal atrophy: longitudinal evaluation in age-related macular degeneration","volume":"130","author":"Wu","year":"2023","journal-title":"Ophthalmology"},{"key":"R13-20250605","doi-asserted-by":"crossref","first-page":"3519","DOI":"10.1167\/iovs.17-21696","article-title":"Optical coherence tomography features preceding the onset of advanced age-related macular degeneration","volume":"58","author":"Ferrara","year":"2017","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R14-20250605","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.oret.2020.06.026","article-title":"Predicting progression of age-related macular degeneration using OCT and fundus photography","volume":"5","author":"Wu","year":"2021","journal-title":"Ophthalmol Retina"},{"key":"R15-20250605","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1136\/bjophthalmol-2020-315935","article-title":"Examining the added value of microperimetry and low luminance deficit for predicting progression in age-related macular degeneration","volume":"105","author":"Wu","year":"2021","journal-title":"Br J Ophthalmol"},{"key":"R16-20250605","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.ophtha.2018.09.015","article-title":"Subthreshold nanosecond laser intervention in age-related macular degeneration: the LEAD randomized controlled clinical trial","volume":"126","author":"Guymer","year":"2019","journal-title":"Ophthalmology"},{"key":"R17-20250605","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/j.oret.2019.07.008","article-title":"Secondary and exploratory outcomes of the subthreshold nanosecond laser intervention randomized trial in age-related macular degeneration: a LEAD study report","volume":"3","author":"Wu","year":"2019","journal-title":"Ophthalmol Retina"},{"key":"R18-20250605","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.ophtha.2012.10.036","article-title":"Clinical classification of age-related macular degeneration","volume":"120","author":"Ferris","year":"2013","journal-title":"Ophthalmology"},{"key":"R19-20250605","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.oret.2016.12.001","article-title":"Subthreshold nanosecond laser intervention in intermediate age-related macular degeneration: study design and baseline characteristics of the laser in early stages of age-related macular degeneration study (report number 1)","volume":"1","author":"Lek","year":"2017","journal-title":"Ophthalmol Retina"},{"key":"R20-20250605","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1177\/1536867X0600600105","article-title":"Explained variation for survival models","volume":"6","author":"Royston","year":"2006","journal-title":"Stata J"},{"key":"R21-20250605","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.jcjo.2021.01.005","article-title":"Natural history of incomplete retinal pigment epithelial and outer retinal atrophy in age-related macular degeneration","volume":"56","author":"Corradetti","year":"2021","journal-title":"Can J Ophthalmol"},{"key":"R22-20250605","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1001\/jamaophthalmol.2021.6067","article-title":"Association of pegcetacoplan with progression of incomplete retinal pigment epithelium and outer retinal atrophy in age-related macular degeneration: a post hoc analysis of the filly randomized clinical trial","volume":"140","author":"Nittala","year":"2022","journal-title":"JAMA Ophthalmol"},{"key":"R23-20250605","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.oret.2021.03.008","article-title":"OCT signs of early atrophy in age-related macular degeneration: interreader agreement: classification of atrophy meetings report 6","volume":"6","author":"Wu","year":"2022","journal-title":"Ophthalmol Retina"},{"key":"R24-20250605","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1159\/000510887","article-title":"Can the onset of atrophic age-related macular degeneration be an acceptable endpoint for preventative trials?","volume":"243","author":"Wu","year":"2020","journal-title":"Ophthalmologica"},{"key":"R25-20250605","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1097\/IAE.0b013e318242b949","article-title":"Effect of change in drusen evolution on photoreceptor inner segment\/outer segment junction","volume":"32","author":"Hartmann","year":"2012","journal-title":"Retina"},{"key":"R26-20250605","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1097\/OPX.0000000000001256","article-title":"Retinal thickness changes throughout the natural history of drusen in age-related macular degeneration","volume":"95","author":"Nivison-Smith","year":"2018","journal-title":"Optom Vis Sci"},{"key":"R27-20250605","doi-asserted-by":"crossref","first-page":"100425","DOI":"10.1016\/j.xops.2023.100425","article-title":"Functional evaluation of retinal pigment epithelium and outer retinal atrophy by high-density targeted microperimetry testing","volume":"4","author":"Wu","year":"2024","journal-title":"Ophthalmol Sci"},{"key":"R28-20250605","doi-asserted-by":"crossref","first-page":"100419","DOI":"10.1016\/j.xops.2023.100419","article-title":"Targeted high-density microperimetry testing of nascent geographic atrophy in age-related macular degeneration","volume":"4","author":"Wu","year":"2024","journal-title":"Ophthalmol Sci"},{"key":"R29-20250605","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/S0002-9394(01)01218-1","article-title":"The age-related eye disease study system for classifying age-related macular degeneration from stereoscopic color fundus photographs: the age-related eye disease study report number 6","volume":"132","year":"2001","journal-title":"Am J Ophthalmol"}],"container-title":["Retina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/IAE.0000000000004080","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T17:01:16Z","timestamp":1749142876000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/IAE.0000000000004080"}},"subtitle":["A Longitudinal Evaluation"],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":29,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/iae.0000000000004080","relation":{},"ISSN":["0275-004X"],"issn-type":[{"value":"0275-004X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]}}}